HUNTINGTON BEACH, CA, and AMSTERDAM, THE NETHERLANDS, March 24, 2009 — Agendia, a world leader in molecular cancer diagnostics, today announced that the Company is scheduled to present at the 16th Anniversary “Future Leaders in the Biotech Industry” Conference on Thursday, April 2, 2009. Presented by BioCentury and Thomson Reuters, the Future Leaders conference has built a reputation as a major biotech investment event, matching strong companies with a select group of specialized institutional investors, investment bankers, sellside/buyside analysts, and pharmaceutical licensing executives.

Agendia’s BioCentury Presentation details are as follows:
Event: BioCentury / Thomson Financial “Future Leaders in the Biotech Industry”
Presenter: Dr. Bernhard Sixt, President & CEO
When: Thursday, April 2, 2009 at 1:30 – 1:55 p.m.
Breakout Session: 1:55 – 2:55 p.m., Room 502
Where: Millennium Broadway Hotel, New York City, Room 502/303
Address: 145 West 44th Street, New York, NY, 10036

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company’s tests aim to help physicians more accurately tailor cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit


Hans Herklots
Head of Corporate Communications
+31.20.462.1557 Office
+31.620.083.509 Cell

Valerie Delva
Ricochet Public Relations
+1.212.679.3300 x131 Office
+1.917.975.3191 Cell